Prostate cancer that has liver metastases is considered to be at an advanced stage. However, prostate cancer itself is not very malignant, and even if liver metastases appear, if anti-androgen therapy is still effective, the situation can be controlled to some extent, and survival is usually expected to be between 5 and 10 years. In the case of hormone resistant prostate cancer with liver metastases, higher level drugs such as abiraterone and enzalutamide need to be applied, if these drugs are not sensitive, only chemotherapy drugs can be used, but the survival rate of the patient will be reduced. However, prostate cancer itself is not very malignant and the expected survival time is about 5 years. However, the survival time of each individual is directly related to the treatment and the condition of the organism, so it is only a prognosis time.